Go back to Resource Center
Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (<91 days) with Suspected or Complicated Intra-abdominal Infections
Book Chapter
Authors:
Benjamin, D.;
Smith, P. B.;
Capparelli, E. V.;
Cohen-Wolkowiez, M.;
Anand, R.;
Martz, K.
Secondary:
Best Pharmaceuticals for Children Act (BPCA) Clinical Reports
Location: Bethesda, MD
PMID:
36630542
URL:
https://www.ncbi.nlm.nih.gov/pubmed/36630542
Abstract:
An open-label, multiple-dose study to determine the safety, tolerability, and pharmacokinetics of meropenem in preterm and term infants less than 91 days of age with suspected or confirmed intra-abdominal infections. Biospecimens are available.
